537 related articles for article (PubMed ID: 32231564)
1. Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice.
Wu M; Yang S; Wang S; Cao Y; Zhao R; Li X; Xing Y; Liu L
Front Pharmacol; 2020; 11():223. PubMed ID: 32231564
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
[TBL] [Abstract][Full Text] [Related]
3. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
Shi Y; Hu J; Geng J; Hu T; Wang B; Yan W; Jiang Y; Li J; Liu S
Biomed Pharmacother; 2018 Nov; 107():1556-1563. PubMed ID: 30257374
[TBL] [Abstract][Full Text] [Related]
4. Peanut skin extract ameliorates high-fat diet-induced atherosclerosis by regulating lipid metabolism, inflammation reaction and gut microbiota in ApoE
Xu M; Lv C; Wang H; Lu Q; Ye M; Zhu X; Liu R
Food Res Int; 2022 Apr; 154():111014. PubMed ID: 35337573
[TBL] [Abstract][Full Text] [Related]
5. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression.
Yang YN; Wang QC; Xu W; Yu J; Zhang H; Wu C
Biomed Pharmacother; 2022 Nov; 155():113749. PubMed ID: 36174380
[TBL] [Abstract][Full Text] [Related]
6. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism.
Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD
Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947
[TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q
Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876
[TBL] [Abstract][Full Text] [Related]
8. Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.
Li X; Su C; Jiang Z; Yang Y; Zhang Y; Yang M; Zhang X; Du Y; Zhang J; Wang L; Jiang J; Hong B
NPJ Biofilms Microbiomes; 2021 Apr; 7(1):36. PubMed ID: 33863898
[TBL] [Abstract][Full Text] [Related]
9. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
Yao Y; Chen H; Yan L; Wang W; Wang D
Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
[TBL] [Abstract][Full Text] [Related]
10. Anti-obesity and Gut Microbiota Modulation Effect of Astragalus Polysaccharides Combined with Berberine on High-Fat Diet-Fed Obese Mice.
Yue SJ; Wang WX; Zhang L; Liu J; Feng WW; Gao H; Tang YP; Yan D
Chin J Integr Med; 2023 Jul; 29(7):617-625. PubMed ID: 34921647
[TBL] [Abstract][Full Text] [Related]
11. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe
Zhu L; Zhang D; Zhu H; Zhu J; Weng S; Dong L; Liu T; Hu Y; Shen X
Atherosclerosis; 2018 Jan; 268():117-126. PubMed ID: 29202334
[TBL] [Abstract][Full Text] [Related]
12. Lingonberries reduce atherosclerosis in Apoe(-/-) mice in association with altered gut microbiota composition and improved lipid profile.
Matziouridou C; Marungruang N; Nguyen TD; Nyman M; Fåk F
Mol Nutr Food Res; 2016 May; 60(5):1150-60. PubMed ID: 26890232
[TBL] [Abstract][Full Text] [Related]
13. Berberine Influences Blood Glucose via Modulating the Gut Microbiome in Grass Carp.
Pan H; Li Z; Xie J; Liu D; Wang H; Yu D; Zhang Q; Hu Z; Shi C
Front Microbiol; 2019; 10():1066. PubMed ID: 31143174
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Berberine on the Gut Microbiota in Apc
Wang H; Guan L; Li J; Lai M; Wen X
Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580
[No Abstract] [Full Text] [Related]
15. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota.
Chen H; Zhang F; Li R; Liu Y; Wang X; Zhang X; Xu C; Li Y; Guo Y; Yao Q
Biomed Pharmacother; 2020 Apr; 124():109829. PubMed ID: 31958765
[TBL] [Abstract][Full Text] [Related]
16. Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota.
Yang S; Li D; Yu Z; Li Y; Wu M
Front Pharmacol; 2021; 12():709629. PubMed ID: 34305616
[TBL] [Abstract][Full Text] [Related]
17. Propamocarb exposure has the potential to accelerate the formation of atherosclerosis in both WT and ApoE
Jin C; Weng Y; Zhang Y; Bao Z; Yang G; Fu Z; Jin Y
Sci Total Environ; 2021 Dec; 800():149602. PubMed ID: 34426332
[TBL] [Abstract][Full Text] [Related]
18. Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE
Ma CY; Shi XY; Wu YR; Zhang Y; Yao YH; Qu HL; Zhang W; Guo YL; Xu RX; Li JJ
Ann Transl Med; 2021 Oct; 9(20):1517. PubMed ID: 34790723
[TBL] [Abstract][Full Text] [Related]
19. Inflammation inhibition and gut microbiota regulation by TSG to combat atherosclerosis in ApoE
Li F; Zhang T; He Y; Gu W; Yang X; Zhao R; Yu J
J Ethnopharmacol; 2020 Jan; 247():112232. PubMed ID: 31606534
[TBL] [Abstract][Full Text] [Related]
20. Berberine Protects against High-Energy and Low-Protein Diet-Induced Hepatic Steatosis: Modulation of Gut Microbiota and Bile Acid Metabolism in Laying Hens.
Wang C; Yang Y; Chen J; Dai X; Xing C; Zhang C; Cao H; Guo X; Hu G; Zhuang Y
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
